The DOI matches its Crossref record; 45 of the 47 references it cites were found in a registry or an index.
Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study
Abstract
Parkinson's-diseased (PD) brains have increased levels of iron in the zona compacta of the substantia nigra (SNc). To determine whether these elevated nigral iron levels may be caused secondarily by degeneration of nigrostriatal dopaminergic (NS-DA) neurons, the NS-DA pathway was unilaterally lesioned in rats through 6-hydroxydopamine (6-OHDA) infusion and nigral iron levels evaluated three weeks later. A significant increase was observed in both iron concentration (+35%) and iron content (+33) within the substantia nigra (SN) ipsilateral to comprehensive 6-OHDA lesions. Moreover, ferric iron staining was dramatically increased within the SNc following 6-OHDA lesions, primarily due to the appearance of iron-positive SNc neurons and infiltrating reactive glial cells. Iron staining in the SN zona reticularis was modestly increased after 6-OHDA lesions, but staining in the neostriatum and globus pallidus was unaffected. These results indicate that loss of NS-DA neurons is associated with increased iron levels in the SN. This suggests that increased nigral iron levels in PD may be secondary to some neurodegenerative process. Nonetheless, even a secondary increase in nigral iron levels may be of pathogenic importance in PD because of iron's ability to catalyze neurotoxic free radical formation and perpetuate neurodegeneration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, in the 6-hydroxydopamine model of Parkinson’s disease the degeneration of nigrostriatal dopaminergic neurons is associated with increased iron accumulation.155”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [155]
Citations
Cites
Measurement of protein using bicinchoninic acid
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90442-7 · Cited by 18,482
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529
The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481
The effect of age on the non-haemin iron in the human brain
Hallgren, B., & Sourander, P. (1958) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1958.tb12607.x · Cited by 1,427
Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease
Dexter, D. T., Carter, C. J., Wells, F. R., Javoy-Agid, F., Agid, Y., Lees, A. J., Jenner, P. G., & MARSDEN, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09133.x · Cited by 1,397
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383
Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
Hirsch, E., Graybiel, A. M., & Agid, Y. A. (1988) · Nature · doi:10.1038/334345a0 · Cited by 1,301
Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149
DEXTER, D. T., CARAYON, A., JAVOY-AGID, F., AGID, Y., WELLS, F. R., DANIEL, S. E., LEES, A. J., JENNER, P., & MARSDEN, C. D. (1991) · Brain · doi:10.1093/brain/114.4.1953 · Cited by 1,043
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
Sofic, E., Riederer, P. F., Heinsen, H., Beckmann, H., Reynolds, G. P., Hebenstreit, G. F., & Youdim, M. B. H. (1988) · Journal of Neural Transmission · doi:10.1007/bf01244786 · Cited by 754
Parkinson's disease: A disorder due to nigral glutathione deficiency?
Perry, T. L., Godin, D. V., & Hansen, S. (1982) · Neuroscience Letters · doi:10.1016/0304-3940(82)90390-1 · Cited by 753
Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases?
Gerlach, M., Ben‐Shachar, D., Riederer, P. F., & Youdim, M. B. H. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63030793.x · Cited by 704
Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease
Sofic, E., Lange, K. W., Jellinger, K. A., & Riederer, P. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90355-b · Cited by 591
Jenner, P. G., Dexter, D. T., Sian, J., Schapira, A. H. V., & MARSDEN, C. D. (1992) · Annals of Neurology · doi:10.1002/ana.410320714 · Cited by 545
Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains
Sofic, E., Paulus, W., Jellinger, K. A., Riederer, P. F., & Youdim, M. B. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02017.x · Cited by 523
The regional distribution and cellular localization of iron in the rat brain
Hill, J. M., & Switzer, R. C. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90046-0 · Cited by 486
Brain iron and ferritin in Parkinson’s and Alzheimer’s diseases
Jellinger, K., Paulus, W., Grundke-Iqbal, I., Riederer, P., & Youdim, M. B. H. (1990) · Journal of Neural Transmission - Parkinson's Disease and Dementia Section · doi:10.1007/bf02252926 · Cited by 445
Self-citationGood, P. F., Olanow, C. W., & Perl, D. P. (1992) · Brain Research · doi:10.1016/0006-8993(92)91334-b · Cited by 427
An introduction to the free radical hypothesis in Parkinson's disease
Olanow, C. W. (1992) · Annals of Neurology · doi:10.1002/ana.410320703 · Cited by 382
Planning and spatial working memory in Parkinson's disease.
Morris, R. G., Downes, J. J., Sahakian, B. J., Evenden, J. L., HEALD, A., & Robbins, T. W. (1988) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.757 · Cited by 366
Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis
Jellinger, K., Kienzl, E., Rumpelmair, G., Riederer, P., Stachelberger, H., Ben‐Shachar, D., & Youdim, M. B. H. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08362.x · Cited by 313
The possible role of iron in the etiopathology of parkinson's disease
Youdim, M. B. H., Ben‐Shachar, D., & Riederer, P. F. (1993) · Movement Disorders · doi:10.1002/mds.870080102 · Cited by 301
Ben‐Shachar, D., Eshel, G., Finberg, J. P. M., & Youdim, M. B. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb11444.x · Cited by 299
Youdim, M. B. H., Ben‐Shachar, D., & Riederer, P. F. (1989) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1989.tb01782.x · Cited by 292
Iron‐Melanin Interaction and Lipid Peroxidation: Implications for Parkinson's Disease
Ben‐Shachar, D., Riederer, P. F., & Youdim, M. B. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb06358.x · Cited by 287
Earle, K. M. (1968) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-196801000-00001 · Cited by 227
Intranigral Iron Injection Induces Behavioral and Biochemical “Parkinsonism” in Rats
Ben‐Shachar, D., & Youdim, M. B. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb06432.x · Cited by 197
Brain neurotransmitter changes in Parkinson's disease
Hornykiewicz, O. (1981) · Movement Disorders · doi:10.1016/b978-0-407-02295-9.50009-6 · Cited by 160
Dunn, A. J. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb01053.x · Cited by 145
Temlett, J. A., Landsberg, J. P., Watt, F., & Orime, G. W. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62010134.x · Cited by 137
Nonidentical distribution of transferrin and ferric iron in human brain
Dwork, A. J., Schon, E. A., & Herbert, J. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90242-4 · Cited by 130
6-Hydroxydopamine releases iron from ferritin and promotes ferritin-dependent lipid peroxidation
Monteiro, H. P., & Winterbourn, C. C. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90512-1 · Cited by 125
Iron in Brain Function and Dysfunction with Emphasis on Parkinson’s Disease
Youdim, M. B. H., Ben‐Shachar, D., & Riederer, P. F. (2008) · European Neurology · doi:10.1159/000116719 · Cited by 105
Sengstock, G. J., Olanow, C. W., Menzies, R. A., Dunn, A. J., & Arendash, G. W. (1993) · Journal of Neuroscience Research · doi:10.1002/jnr.490350109 · Cited by 105
An autoradiographic study of the uptake and distribution of iron by the brain of the young rat
Dwork, A. J., Lawler, G., ZYBERT, P. A., Durkin, M. M., Osman, M., Willson, N. J., & Barkai, A. I. (1990) · Brain Research · doi:10.1016/0006-8993(90)90950-g · Cited by 98
Iron induces degeneration of nigrostriatal neurons
Sengstock, G. J., Olanow, C. W., Dunn, A. J., & Arendash, G. W. (1992) · Brain Research Bulletin · doi:10.1016/0361-9230(92)90118-h · Cited by 90
Dexter, D. T., Sian, J., Jenner, P. G., & MARSDEN, C. D. (1993) · PubMed · Cited by 82
Hill, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)91348-4 · Cited by 73
Modulation by neuromelanin of the availability and reactivity of metal ions
Swartz, H. M., Sarna, T., & Zecca, L. (1992) · Annals of Neurology · doi:10.1002/ana.410320712 · Cited by 73
The role of iron in the basal ganglion.
Youdim, M. B. H., Ben‐Shachar, D., Yehuda, S., & Riederer, P. F. (1990) · PubMed · Cited by 55
Toxin-Induced Models of Neurological Disorders
Barker, R. B. (1995) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.59.1.109-a · Cited by 52
MRI, brain iron and experimental Parkinson's disease
Hall, S., Rutledge, J. N., & Schallert, T. J. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90247-i · Cited by 49
Ben‐Shachar, D., Pinhassi, B., & Youdim, M. B. H. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90292-x · Cited by 16
Leenders, K. L., Antonini, A., Schwarzbach, R., Smith-Jones, P. M., Reist, H. W., Ben‐Shachar, D., Youdim, M. B. H., & Henn, V. S. (1994) · PubMed · Cited by 13
Intranigral Iron Infusion as a Model for Parkinson’s Disease
Arendash, G. W., Sengstock, G. J., Olanow, C. W., Barone, S., & Dunn, A. J. (1994) · Springer eBooks · doi:10.1007/978-1-4899-1447-7_7 · Cited by 6
Research works printed but not linked: 1
- Antonini, 1993, Brain iron uptake in patients with Parkinson's disease (PD) measured by positron emmission tomography (PET), J. Cereb. Blood Flow Metab., 13, S364
Cited by
Sorted by citations
The role of iron in brain ageing and neurodegenerative disorders
Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70117-6 · Cited by 1,819
Iron, brain ageing and neurodegenerative disorders
Zecca, L., Youdim, M. B. H., Riederer, P., Connor, J. R., & Crichton, R. R. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1537 · Cited by 1,801
ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE
Olanow, C. W., & Tatton, W. G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.123 · Cited by 1,409
Blum, D. L., Torch, S., Lambeng, N., Nissou, M.-F., Benabid, A., Sadoul, R., & Verna, J. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00003-x · Cited by 1,269
Metal-triggered Structural Transformations, Aggregation, and Fibrillation of Human α-Synuclein
Uversky, V. N., Li, J., & Fink, A. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105343200 · Cited by 1,103
Metadata
- Authors
- Oestreicher, E., Sengstock, G. J., Riederer, P., Olanow, C. W., Dunn, A. J., & Arendash, G. W.
- Affiliations
- University of Würzburg (DE)
- University of South Florida (US)
- Louisiana State University (US)
- Corresponding author
- Arendash, G.W.
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 1994-10
- Volume
- 660
- Issue
- 1
- Pages
- 8-18
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W2049800884
- Cited by
- 156
- References
- 47
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 4 · 2022: 7 · 2021: 7 · 2020: 3 · 2019: 2 · 2018: 2 · 2017: 3 · 2016: 1 · 2015: 4 · 2014: 5 · 2013: 7 · 2012: 4
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- Parkinson's disease, nigrostriatal dopaminergic neurons, substantia nigra, iron accumulation, 6-hydroxydopamine lesion, neurodegeneration, reactive glial cells
- MeSH terms
- Amphetamine, Animals, Behavior, Animal, Corpus Striatum, Histocytochemistry, Iron, Male, Medial Forebrain Bundle, Nerve Degeneration, Neurons, Stereotyped Behavior, Substantia Nigra, Oxidopamine, Rats, Sprague-Dawley, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review